Creatine Kinase
CardíacoÚltima revisión: 7 de abril de 2026. Enfoque de fuentes: contexto estándar de interpretación de laboratorio, material médico de referencia y orientación clínica o de salud pública cuando corresponde.
¿Qué es Creatine Kinase?
Creatine kinase (CK), also known as creatine phosphokinase (CPK), is an enzyme that catalyzes the reversible transfer of a phosphate group from phosphocreatine to ADP, regenerating ATP—the cell's primary energy currency. This reaction is critical in tissues with high and fluctuating energy demands, particularly skeletal muscle, cardiac muscle, and the brain. CK exists in three isoenzyme forms: CK-MM (predominant in skeletal muscle, accounting for ~95% of total CK in serum), CK-MB (found mainly in cardiac muscle, typically 1–3% of total CK), and CK-BB (found in the brain and smooth muscle, rarely detected in serum).
Total CK is a well-established marker of muscle damage. When muscle cells are injured—whether from exercise, trauma, ischemia, or disease—CK leaks into the bloodstream in proportion to the degree of damage. While CK-MB was historically the primary cardiac biomarker for diagnosing myocardial infarction, high-sensitivity troponin assays have largely supplanted it for this purpose. Total CK remains essential for diagnosing rhabdomyolysis, monitoring myopathies and muscular dystrophies, and detecting statin-related muscle toxicity.
Por qué importa
CK is the most sensitive widely available marker for skeletal muscle injury. In rhabdomyolysis, CK levels can exceed 10,000–100,000 U/L or higher, and the degree of elevation correlates with the risk of acute kidney injury from myoglobin-induced tubular damage. CK monitoring is also critical for patients on statin therapy, as statins can rarely cause myopathy or rhabdomyolysis. In neuromuscular diseases such as Duchenne muscular dystrophy, CK levels are typically elevated 10–100 times normal even before clinical symptoms appear, making it useful for early detection and monitoring. CK-MB, while less used now, still plays a role in detecting reinfarction in patients who have already had a heart attack, as it rises and falls more quickly than troponin.
Rangos de referencia normales
| Grupo | Rango | Unidad |
|---|---|---|
| Adult Men | 39–308 | U/L |
| Adult Women | 26–192 | U/L |
| Children | 60–305 | U/L |
| Newborns | 68–580 | U/L |
Los rangos de referencia pueden variar entre laboratorios. Compara siempre tus resultados con los rangos proporcionados por tu laboratorio.
Qué significan los niveles altos de CK
Causas comunes
- Rhabdomyolysis (crush injury, prolonged immobilization, hyperthermia)
- Intense or prolonged exercise (especially eccentric exercise)
- Myocardial infarction (CK-MB fraction elevated)
- Muscular dystrophies (Duchenne, Becker)
- Inflammatory myopathies (polymyositis, dermatomyositis)
- Hypothyroidism-associated myopathy
- Statin or other drug-induced myopathy
- Seizures (prolonged)
- Intramuscular injections
- Malignant hyperthermia
Posibles síntomas
- Muscle pain, tenderness, and swelling
- Muscle weakness
- Dark brown or tea-colored urine (myoglobinuria in rhabdomyolysis)
- Decreased urine output (if acute kidney injury develops)
- Chest pain with cardiac CK-MB elevation
- Fatigue and malaise
Qué hacer: The clinical context dictates management. For suspected rhabdomyolysis (CK >5x normal with risk factors), aggressive intravenous fluid resuscitation is critical to prevent kidney damage. Monitor renal function, electrolytes (especially potassium and calcium), and urine output. For suspected cardiac causes, troponin is the preferred biomarker. If statin-related, hold the statin and recheck CK. For neuromuscular disease, refer for neurological evaluation and possible muscle biopsy or genetic testing.
Qué significan los niveles bajos de CK
Causas comunes
- Low muscle mass (sarcopenia, cachexia, or prolonged immobility)
- Connective tissue diseases (rheumatoid arthritis, lupus—some patients)
- Alcoholic liver disease (reduced muscle mass)
- Early pregnancy
Posibles síntomas
- Low CK itself does not cause symptoms
- May reflect underlying muscle wasting or deconditioning
Qué hacer: Low CK is usually not clinically concerning and often reflects low muscle mass. If accompanied by muscle weakness, consider a neurological evaluation. Ensure adequate nutrition and physical activity. No specific treatment is needed for isolated low CK.
¿Cuándo se recomienda la prueba de CK?
- When rhabdomyolysis is suspected (dark urine, muscle pain after crush injury or extreme exertion)
- When monitoring patients on statin therapy who develop muscle symptoms
- In the evaluation of suspected myopathies or muscular dystrophies
- As part of the workup for suspected myocardial infarction (CK-MB, though troponin is preferred)
- When monitoring drug-related muscle toxicity (colchicine, daptomycin)
Preguntas frecuentes
Biomarcadores relacionados
Referencias y enfoque de revisión
Las páginas del glosario de biomarcadores son explicaciones educativas y deben interpretarse junto con los rangos de referencia y comentarios proporcionados por tu laboratorio y tu profesional de salud. Para conocer nuestros estándares editoriales y proceso de revisión, consulta nuestra Política editorial y nuestro Proceso de revisión de contenido.
¿Quieres analizar tus niveles de CK?
Sube tus resultados de laboratorio para recibir un análisis instantáneo con IA de todos tus biomarcadores.
Subir resultados de laboratorio →Aviso médico: Esta información es solo educativa y no sustituye el consejo, diagnóstico ni tratamiento médico profesional. Los rangos de referencia pueden variar entre laboratorios. Consulta siempre a tu profesional sanitario para interpretar tus resultados concretos.